23
Feb
Feb
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).Read more…Read More
Tag Archives: Ozempic
23
Feb
Feb
The real cost? Your medical license…Read More
23
Feb
Feb
Collectively, the top eight blockbuster drugs of 2024 generated over $116 billion in sales last year. Looking closer at these figures provides insight into the shifting landscape of the pharmaceutical industry, including the rise of weight-loss drugs, the shrinking demand of COVID-19 vaccines, and the necessity of…Read more…Read More
22
Feb
Feb
Ozempic side effects You don’t have permission to access “http://www.medpagetoday.com/endocrinology/diabetes/114324” on this server. Reference #18.2e257e68.1740192703.70917148 https://errors.edgesuite.net/18.2e257e68.1740192703.70917148 Read More
blindness, Ozempic
Ozempic and blindness, McDonald’s and chicken, Coca-Cola and tariffs: Business news roundup
16
Feb
Feb
Popular diabetes and weight-loss drugs, including Ozempic (NVO) and Zepbound (LLY), may have a potential link with several eye conditions that can cause vision loss, according to a new investigatory review published recently in the scientific journal JAMA Ophthalmology. Read more…Read More
16
Feb
Feb
Semaglutide, the active ingredient in both Ozempic and Wegovy, could be a possible treatment for alcohol abuse…Read More
09
Feb
Feb
Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish pharmaceutical giant warns that sales growth for all its drugs — including Ozempic — is expected to slow in the coming year.Read more…Read More
03
Feb
Feb
Novo Nordisk (NVO) announced today that its blockbuster drug Ozempic was approved by the Food and Drug Administration (FDA) as the first GLP-1 treatment for chronic kidney disease among people with type 2 diabetes.Read more…Read More
31
Jan
Jan
Ozempic weight reduction The US Food and Drug Administration (FDA) approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and cardiovascular death in adults with both type 2 diabetes and chronic kidney disease. The approval is based on the phase 3b results of the international FLOW kidney outcomes trial, which involved […]
29
Jan
Jan
Ozempic liver function You don’t have permission to access “http://www.medpagetoday.com/nephrology/diabetes/113985” on this server. Reference #18.351dc917.1738110839.6941054 https://errors.edgesuite.net/18.351dc917.1738110839.6941054 Read More
